Some Experts Urge Eradication of U.S., Russian Smallpox Stocks

Global Security Newswire Staff
Add to Briefcase
Global Security Newswire Staff
May 5, 2014, 9:06 a.m.

Ahead of a ma­jor glob­al pub­lic health meet­ing this month, a num­ber of ex­perts are ur­ging Wash­ing­ton and Mo­scow to des­troy their small­pox samples.

The health min­is­ters of coun­tries be­long­ing to the World Health Or­gan­iz­a­tion are slated to de­bate in Geneva, Switzer­land, wheth­er the United States and Rus­sia should be called on to elim­in­ate their strains of the live vari­ola vir­us. U.S. of­fi­cials ar­gue that the samples should be re­tained to per­mit more re­search on im­proved small­pox coun­ter­meas­ures. But some out­side ex­perts say the ma­ter­i­al is too dan­ger­ous to war­rant con­tin­ued re­ten­tion, the As­so­ci­ated Press re­por­ted on Sunday.

The World Health As­sembly, the gov­ern­ing body of the World Health Or­gan­iz­a­tion, has re­peatedly delayed es­tab­lish­ing a date for when the small­pox strains — the last known re­main­ing samples in the world of the deadly vir­us — should be des­troyed. En­hanced ver­sions of the small­pox vac­cine are cur­rently be­ing stock­piled. Mean­while, two an­ti­vir­al med­ic­a­tions for the vir­us are un­der de­vel­op­ment.

“We be­lieve that the small­pox re­search pro­gram is ef­fect­ively com­plete and the case for de­struc­tion is stronger than ever,” said Lim Li Ching, a biosafety ex­pert as­so­ci­ated with the Third World Net­work, which ad­voc­ates for des­troy­ing the small­pox strains in a two-year time­frame.

D.A. Hende­r­son, who pre­vi­ously headed the suc­cess­ful WHO cam­paign to erad­ic­ate small­pox from nature, told AP that re­tain­ing live samples is no longer sci­en­tific­ally war­ran­ted as the vir­us’ ge­net­ic code is already known.

“Let’s des­troy the vir­us and be done with it,” Hende­r­son said. “We would be bet­ter off spend­ing our money in bet­ter ways” such as on de­vel­op­ing en­hanced coun­ter­meas­ures for com­bat­ing oth­er dis­ease agents that could be used as bio­lo­gic­al weapons.

Through syn­thet­ic bio­logy, the small­pox vir­us could be man­u­fac­tured in a labor­at­ory if ne­ces­sary in or­der to de­vel­op new med­ic­al coun­ter­meas­ures, ex­perts say. However, the same tech­no­logy could be mis­used by bad act­ors look­ing to ac­quire small­pox for use in an act of bio­lo­gic­al ter­ror­ism.

“Syn­thet­ic bio­logy adds a new wrinkle to it,” U.S. Health and Hu­man Ser­vices As­sist­ant Sec­ret­ary for Glob­al Af­fairs Jimmy Kolk­er said in an in­ter­view. “We now aren’t as sure that our coun­ter­meas­ures are go­ing to be as ef­fect­ive as we’d thought even five years ago.”

What We're Following See More »
HEALTH IN QUESTION
Sen. Cochran Back to Washington Tuesday
5 hours ago
THE LATEST
THIRD VERSION OF THE BAN
Federal Judge Temporarily Stops Trump’s Travel Ban
6 hours ago
THE LATEST

"A federal district court in Hawaii has temporarily blocked the third iteration of President Trump's travel ban. Judge Derrick Watson said the new targeted restrictions on travel from eight countries Trump issued on Sept. 24 suffers the same problems as the previous order."

Source:
FORMER ELI LILLY EXEC
Trump Leaning Towards Alex Azar for HHS
6 hours ago
THE DETAILS

"President Donald Trump is leaning toward nominating Alex Azar, a former pharmaceutical industry executive and George W. Bush administration official, to serve as Health and Human Services secretary, according to two White House officials...Azar is a veteran of HHS. He served as the department’s general counsel and deputy secretary during the Bush administration." He led Eli Lilly's U.S. operations from 2012-17.

Source:
ENOUGH SUPPORT TO PASS?
Senators Reach Bipartisan ACA Deal
7 hours ago
THE LATEST

"Sen. Lamar Alexander says he and Sen. Patty Murray have reached a deal to fund the Affordable Care Act's cost-sharing subsidies in exchange for giving states more regulatory flexibility with the law." Axios is watching to see if the deal will gather support.

Source:
INDEX UP MORE THAN 20% SINCE ELECTION
Dow Jones Hits 23,000 Threshold
9 hours ago
THE DETAILS
×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login